Sfoglia per Autore
Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice
2002 Battaglia, G.; Busceti, C. L.; Cuomo, L.; Giorgi, F. S.; Orzi, Francesco; DE BLASI, Antonio; Nicoletti, Ferdinando; Ruggieri, Stefano; Fornai, F.
Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
2003 Battaglia, Giuseppe; Carla L., Busceti; Fabrizio, Pontarelli; Francesca, Biagioni; Francesco, Fornai; Antonio, Paparelli; Bruno, Valeria Maria Gloria; Ruggieri, Stefano; Nicoletti, Ferdinando
Amphetamines induce ubiquitin-positive inclusions within striatal cells
2003 F., Fornai; G., Lazzeri; P., Lenzi; M., Gesi; M., Ferrucci; P., Soldani; A., Pellegrini; L., Capobianco; DE BLASI, Antonio; Ruggieri, Stefano; A., Paparelli
Dual dopamine agonist treatment in Parkinson’s disease
2003 Stocchi, F.; Vacca, L.; Berardelli, Alfredo; Onofrj, M.; Manfredi, M.; Ruggieri, Stefano
Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson’s disease
2003 Stocchi, F; Berardelli, Alfredo; Vacca, L; Barbato, L; Monge, A; Nordera, G; Ruggieri, Stefano
Similarities between methamphetamine toxicity and proteasome inhibition
2004 F., Fornai; P., Lenzi; M., Gesi; M., Ferrucci; G., Lazzeri; L., Capobianco; DE BLASI, Antonio; G., Battaglia; Nicoletti, Ferdinando; Ruggieri, Stefano; A., Paparelli
CAPS1 regulates catecholamine loading of large dense-core vesicles
2005 Dina, Speidel; Cathrin E., Bruederle; Carsten, Enk; Thomas, Voets; Frederique, Varoqueaux; Kerstin, Reim; Ute, Becherer; Francesco, Fornai; Ruggieri, Stefano; Yvonne, Holighaus; Eberhard, Weihe; Dieter, Bruns; Nils, Brose; Jens, Rettig
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and {alpha}-synuclein.
2005 Fornai, F; Schluter, Om; Lenzi, P; Gesi, M; Ruffoli, R; Ferrucci, M; Lazzeri, G; Busceti, Cl; Pontarelli, F; Battaglia, G; Pellegrini, A; Nicoletti, Ferdinando; Ruggieri, Stefano; Paparelli, A; Sudhof, T. C.
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study.
2005 Stocchi, F; Vacca, L; Ruggieri, Stefano; Olanow, Cw
InPC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition
2006 G., Lazzeri; P., Lenzi; M., Gesi; M., Ferrucci; F., Fulceri; Ruggieri, Stefano; Bruno, Valeria Maria Gloria; F., Fornai; S., Ali
Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity
2006 Fornai, F; Lazzeri, G; BANDETTINI DI POGGIO, A; Soldani, P; DE BLASI, Antonio; Nicoletti, Ferdinando; Ruggieri, Stefano; Paparelli, A.
Inclusion dynamics in PC12 is comparable between amphetamines and MPTP
2006 M., Gesi; G., Lazzeri; M., Ferrucci; A., Pellegrini; P., Lenzi; Ruggieri, Stefano; F., Fornai; A., Paparelli
The neurotoxicity of amphetamines: Bridging drugs of abuse and neurodegenerative disorders
2006 Iacovelli, Luisa; Federica, Fulceri; DE BLASI, Antonio; Nicoletti, Ferdinando; Ruggieri, Stefano; Francesco, Fornai
Lithium delays progression of amyotrophic lateral sclerosis
2008 F., Fornai; P., Longone; L., Cafaro; O., Kastsiuchenka; M., Ferrucci; M. L., Manca; G., Lazzeri; A., Spalloni; N., Bellio; P., Lenzi; N., Modugno; G., Siciliano; C., Isidoro; L., Murri; Ruggieri, Stefano; A., Paparelli
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
2009 Olanow, Cw; Rascol, O; Hauser, R; Feigin, Pd; Jankovic, J; Lang, A; Langston, W; Melamed, E; Poewe, W; Stocchi, F; Tolosa, E; ADAGIO STUDY, Investigators; Collaborators, ; Bueri, J; Garretto, N; Gershanik, O; Giannaula, R; Micheli, F; Wolf, E; Guttman, M; Hobson, D; Jog, M; King, D; Mendis, T; Miyasaki, J; Panisset, M; Pourcher, E; Rajput, A; Ranawaya, R; Tsui, J; Cesaro, P; Damier, P; Destee, A; Durif, F; Slaoui, T; Tison, F; Viallet, F; Deuschl, G; Gasser, T; Ludolph, A; Oehlwein, C; Przuntek, H; Reifschneider, G; Schnitzler, A; Trenkwalder, C; Bokor, M; Katona, A; Lajtos, J; Nikl, J; Takats, A; Valikovics, A; Badarny, S; Djaldetti, R; Giladi, N; Hassin, S; Rabey, Jm; Reches, A; Schwartz, M; Wirguin, I; Albanese, A; Bentivoglio, A; Bonuccelli, U; Calzetti, S; Comi, G; Curatola, L; Ferrarese, C; Lamberti, P; Marconi, R; Martignoni, E; Meco, Giuseppe; Ruggieri, Stefano; Stocchi, F; Bomhof, Ma; Hovestadt, A; Krul, Jm; Leenders, Kl; Cunha, L; Ferreira, J; Bajenaru, Oa; Carciumaru, N; Bulboaca, Ac; Pascu, I; Simu, M; Calopa, M; FERNÁNDEZ GARCÍA, Jm; Kulisevsky, J; Linazasoro, C; Miquel, F; Posada, Ij; Martí, Mj; Burn, D; Macmahon, D; Barker, R; Allen, N; Barbour, P; Bertoni, J; Bharucha, K; Bose, S; Drasby, E; Elble, R; Elmer, L; Evans, B; Factor, S; Fernandez, H; Friedman, J; Hull, K; Golbe, L; Goudreau, J; Guttuso, T; Hassan, M; Hauser, R; Hermanowicz, N; Houser, M; Hurtig, H; Isaacson, S; Jennings, D; Kompoliti, A; Morgan, J; Murphy, J; Nausieda, P; Pahwa, R; Parashos, S; O'Suilleabhain, P; Racette, B; Reich, S; Roberts, J; Rothstein, T; Sahay, A; SAINT HILAIRE, M; Schiess, M; Scott, B; Shahed, J; Simuni, T; Singer, C; Smith, R; Struck, L; Sutton, J; Swope, D; Tagliati, M; Tetrud, J; Togasaki, D; Watts, R.
Entacapone in elderly Parkinsonian patients experiencing levodopa-related wearing-off: a pilot study
2009 Pellicano, Clelia; Benincasa, Dario; Morena, Giovannelli; Buttarelli, Francesca Romana; Ruggieri, Stefano; Pontieri, FRANCESCO ERNESTO
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
2009 G., Comi; V., Martinelli; M., Rodegher; L., Moiola; O., Bajenaru; A., Carra; I., Elovaara; F., Fazekas; H. P., Hartung; J., Hillert; J., King; S., Komoly; C., Lubetzki; X., Montalban; K. M., Myhr; M., Ravnborg; P., Rieckmann; D., Wynn; C., Young; M., Filippi; Ruggieri, Stefano
Motor follow-up of parkinsonian patients after deep-brain stimulation
2011 Caranci, G.; Lena, F.; Modugno, N.; Ruggieri, S.; Romanelli, P.; Manfredi, M.
Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: Which matters most?
2012 DI BIASIO, Francesca; Vanacore, Nicola; Fasano, Alfonso; Modugno, Nicola; Gandolfi, Barbara; Lena, Francesco; Grillea, Giovanni; Pietracupa, Sara; Caranci, Giovanni; Ruggieri, Stefano
A clinical overview of non-motor symptoms in Parkinson's disease
2013 Modugno, N.; Lena, F.; Di Biasio, F.; Cerrone, G.; Ruggieri, S.; Fornai, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice | 2002 | Battaglia, G.; Busceti, C. L.; Cuomo, L.; Giorgi, F. S.; Orzi, Francesco; DE BLASI, Antonio; Nicoletti, Ferdinando; Ruggieri, Stefano; Fornai, F. | |
| Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice | 2003 | Battaglia, Giuseppe; Carla L., Busceti; Fabrizio, Pontarelli; Francesca, Biagioni; Francesco, Fornai; Antonio, Paparelli; Bruno, Valeria Maria Gloria; Ruggieri, Stefano; Nicoletti, Ferdinando | |
| Amphetamines induce ubiquitin-positive inclusions within striatal cells | 2003 | F., Fornai; G., Lazzeri; P., Lenzi; M., Gesi; M., Ferrucci; P., Soldani; A., Pellegrini; L., Capobianco; DE BLASI, Antonio; Ruggieri, Stefano; A., Paparelli | |
| Dual dopamine agonist treatment in Parkinson’s disease | 2003 | Stocchi, F.; Vacca, L.; Berardelli, Alfredo; Onofrj, M.; Manfredi, M.; Ruggieri, Stefano | |
| Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson’s disease | 2003 | Stocchi, F; Berardelli, Alfredo; Vacca, L; Barbato, L; Monge, A; Nordera, G; Ruggieri, Stefano | |
| Similarities between methamphetamine toxicity and proteasome inhibition | 2004 | F., Fornai; P., Lenzi; M., Gesi; M., Ferrucci; G., Lazzeri; L., Capobianco; DE BLASI, Antonio; G., Battaglia; Nicoletti, Ferdinando; Ruggieri, Stefano; A., Paparelli | |
| CAPS1 regulates catecholamine loading of large dense-core vesicles | 2005 | Dina, Speidel; Cathrin E., Bruederle; Carsten, Enk; Thomas, Voets; Frederique, Varoqueaux; Kerstin, Reim; Ute, Becherer; Francesco, Fornai; Ruggieri, Stefano; Yvonne, Holighaus; Eberhard, Weihe; Dieter, Bruns; Nils, Brose; Jens, Rettig | |
| Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and {alpha}-synuclein. | 2005 | Fornai, F; Schluter, Om; Lenzi, P; Gesi, M; Ruffoli, R; Ferrucci, M; Lazzeri, G; Busceti, Cl; Pontarelli, F; Battaglia, G; Pellegrini, A; Nicoletti, Ferdinando; Ruggieri, Stefano; Paparelli, A; Sudhof, T. C. | |
| Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study. | 2005 | Stocchi, F; Vacca, L; Ruggieri, Stefano; Olanow, Cw | |
| InPC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition | 2006 | G., Lazzeri; P., Lenzi; M., Gesi; M., Ferrucci; F., Fulceri; Ruggieri, Stefano; Bruno, Valeria Maria Gloria; F., Fornai; S., Ali | |
| Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity | 2006 | Fornai, F; Lazzeri, G; BANDETTINI DI POGGIO, A; Soldani, P; DE BLASI, Antonio; Nicoletti, Ferdinando; Ruggieri, Stefano; Paparelli, A. | |
| Inclusion dynamics in PC12 is comparable between amphetamines and MPTP | 2006 | M., Gesi; G., Lazzeri; M., Ferrucci; A., Pellegrini; P., Lenzi; Ruggieri, Stefano; F., Fornai; A., Paparelli | |
| The neurotoxicity of amphetamines: Bridging drugs of abuse and neurodegenerative disorders | 2006 | Iacovelli, Luisa; Federica, Fulceri; DE BLASI, Antonio; Nicoletti, Ferdinando; Ruggieri, Stefano; Francesco, Fornai | |
| Lithium delays progression of amyotrophic lateral sclerosis | 2008 | F., Fornai; P., Longone; L., Cafaro; O., Kastsiuchenka; M., Ferrucci; M. L., Manca; G., Lazzeri; A., Spalloni; N., Bellio; P., Lenzi; N., Modugno; G., Siciliano; C., Isidoro; L., Murri; Ruggieri, Stefano; A., Paparelli | |
| A double-blind, delayed-start trial of rasagiline in Parkinson's disease. | 2009 | Olanow, Cw; Rascol, O; Hauser, R; Feigin, Pd; Jankovic, J; Lang, A; Langston, W; Melamed, E; Poewe, W; Stocchi, F; Tolosa, E; ADAGIO STUDY, Investigators; Collaborators, ; Bueri, J; Garretto, N; Gershanik, O; Giannaula, R; Micheli, F; Wolf, E; Guttman, M; Hobson, D; Jog, M; King, D; Mendis, T; Miyasaki, J; Panisset, M; Pourcher, E; Rajput, A; Ranawaya, R; Tsui, J; Cesaro, P; Damier, P; Destee, A; Durif, F; Slaoui, T; Tison, F; Viallet, F; Deuschl, G; Gasser, T; Ludolph, A; Oehlwein, C; Przuntek, H; Reifschneider, G; Schnitzler, A; Trenkwalder, C; Bokor, M; Katona, A; Lajtos, J; Nikl, J; Takats, A; Valikovics, A; Badarny, S; Djaldetti, R; Giladi, N; Hassin, S; Rabey, Jm; Reches, A; Schwartz, M; Wirguin, I; Albanese, A; Bentivoglio, A; Bonuccelli, U; Calzetti, S; Comi, G; Curatola, L; Ferrarese, C; Lamberti, P; Marconi, R; Martignoni, E; Meco, Giuseppe; Ruggieri, Stefano; Stocchi, F; Bomhof, Ma; Hovestadt, A; Krul, Jm; Leenders, Kl; Cunha, L; Ferreira, J; Bajenaru, Oa; Carciumaru, N; Bulboaca, Ac; Pascu, I; Simu, M; Calopa, M; FERNÁNDEZ GARCÍA, Jm; Kulisevsky, J; Linazasoro, C; Miquel, F; Posada, Ij; Martí, Mj; Burn, D; Macmahon, D; Barker, R; Allen, N; Barbour, P; Bertoni, J; Bharucha, K; Bose, S; Drasby, E; Elble, R; Elmer, L; Evans, B; Factor, S; Fernandez, H; Friedman, J; Hull, K; Golbe, L; Goudreau, J; Guttuso, T; Hassan, M; Hauser, R; Hermanowicz, N; Houser, M; Hurtig, H; Isaacson, S; Jennings, D; Kompoliti, A; Morgan, J; Murphy, J; Nausieda, P; Pahwa, R; Parashos, S; O'Suilleabhain, P; Racette, B; Reich, S; Roberts, J; Rothstein, T; Sahay, A; SAINT HILAIRE, M; Schiess, M; Scott, B; Shahed, J; Simuni, T; Singer, C; Smith, R; Struck, L; Sutton, J; Swope, D; Tagliati, M; Tetrud, J; Togasaki, D; Watts, R. | |
| Entacapone in elderly Parkinsonian patients experiencing levodopa-related wearing-off: a pilot study | 2009 | Pellicano, Clelia; Benincasa, Dario; Morena, Giovannelli; Buttarelli, Francesca Romana; Ruggieri, Stefano; Pontieri, FRANCESCO ERNESTO | |
| Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial | 2009 | G., Comi; V., Martinelli; M., Rodegher; L., Moiola; O., Bajenaru; A., Carra; I., Elovaara; F., Fazekas; H. P., Hartung; J., Hillert; J., King; S., Komoly; C., Lubetzki; X., Montalban; K. M., Myhr; M., Ravnborg; P., Rieckmann; D., Wynn; C., Young; M., Filippi; Ruggieri, Stefano | |
| Motor follow-up of parkinsonian patients after deep-brain stimulation | 2011 | Caranci, G.; Lena, F.; Modugno, N.; Ruggieri, S.; Romanelli, P.; Manfredi, M. | |
| Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: Which matters most? | 2012 | DI BIASIO, Francesca; Vanacore, Nicola; Fasano, Alfonso; Modugno, Nicola; Gandolfi, Barbara; Lena, Francesco; Grillea, Giovanni; Pietracupa, Sara; Caranci, Giovanni; Ruggieri, Stefano | |
| A clinical overview of non-motor symptoms in Parkinson's disease | 2013 | Modugno, N.; Lena, F.; Di Biasio, F.; Cerrone, G.; Ruggieri, S.; Fornai, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile